174 related articles for article (PubMed ID: 26662519)
1. Identification of a Novel Toll-like Receptor 7 Endogenous Ligand in Rheumatoid Arthritis Synovial Fluid That Can Provoke Arthritic Joint Inflammation.
Kim SJ; Chen Z; Essani AB; Elshabrawy HA; Volin MV; Volkov S; Swedler W; Arami S; Sweiss N; Shahrara S
Arthritis Rheumatol; 2016 May; 68(5):1099-110. PubMed ID: 26662519
[TBL] [Abstract][Full Text] [Related]
2. TLR7 endogenous ligands remodel glycolytic macrophages and trigger skin-to-joint crosstalk in psoriatic arthritis.
Van Raemdonck K; Umar S; Palasiewicz K; Romay B; Volkov S; Arami S; Sweiss N; Shahrara S
Eur J Immunol; 2021 Mar; 51(3):714-720. PubMed ID: 33079387
[TBL] [Abstract][Full Text] [Related]
3. IRAK4 inhibition: a promising strategy for treating RA joint inflammation and bone erosion.
Umar S; Palasiewicz K; Van Raemdonck K; Volin MV; Romay B; Amin MA; Zomorrodi RK; Arami S; Gonzalez M; Rao V; Zanotti B; Fox DA; Sweiss N; Shahrara S
Cell Mol Immunol; 2021 Sep; 18(9):2199-2210. PubMed ID: 32415262
[TBL] [Abstract][Full Text] [Related]
4. TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells.
Ito H; Hamerman JA
Eur J Immunol; 2012 Jan; 42(1):176-85. PubMed ID: 21956652
[TBL] [Abstract][Full Text] [Related]
5. Extracellular microRNAs induce dendritic cell-dependent joint inflammation and potentiate osteoclast differentiation via TLR7/8 engagement.
Gaudenzi C; Schioppa T; Passari M; Zucchi G; Tiberio L; Vahidi Y; Scutera S; Musso T; Sozzani S; Del Prete A; Salvi V; Bosisio D
J Autoimmun; 2024 May; 145():103189. PubMed ID: 38442677
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 primed platelets-derived microRNAs enhance NETs formation by extracellular vesicle transmission and TLR7/8 activation.
Liao TL; Liu HJ; Chen DY; Tang KT; Chen YM; Liu PY
Cell Commun Signal; 2023 Oct; 21(1):304. PubMed ID: 37904132
[TBL] [Abstract][Full Text] [Related]
7. Role of microRNAs and their downstream target transcription factors in zebrafish thrombopoiesis.
Al Qaryoute A; Fallatah W; Dhinoja S; Raman R; Jagadeeswaran P
Sci Rep; 2023 Sep; 13(1):16066. PubMed ID: 37752184
[TBL] [Abstract][Full Text] [Related]
8. Ash1L ameliorates psoriasis via limiting neuronal activity-dependent release of miR-let-7b.
Du WJ; Yang H; Tong F; Liu S; Zhang C; Chen Y; Yan Y; Xiang YW; Hua LY; Gong Y; Xu ZX; Liu X; Jiang X; Lu M; Guan JS; Han Q
Br J Pharmacol; 2024 Apr; 181(7):1107-1127. PubMed ID: 37766518
[TBL] [Abstract][Full Text] [Related]
9. Role of MicroRNAs and their Downstream Target Transcription Factors in Zebrafish Thrombopoiesis.
Qaryoute AA; Fallatah W; Dhinoja S; Raman R; Jagadeeswaran P
Res Sq; 2023 Apr; ():. PubMed ID: 37162944
[TBL] [Abstract][Full Text] [Related]
10. Targeting TLR Signaling Cascades in Systemic Lupus Erythematosus and Rheumatoid Arthritis: An Update.
Kalliolias GD; Basdra EK; Papavassiliou AG
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255243
[TBL] [Abstract][Full Text] [Related]
11. Role of microRNAs deregulation in initiation of rheumatoid arthritis: A retrospective observational study.
Li Z; Zhao W; Wang M; Hussain MZ; Mahjabeen I
Medicine (Baltimore); 2024 Jan; 103(3):e36595. PubMed ID: 38241560
[TBL] [Abstract][Full Text] [Related]
12. Receptor targeting drug delivery strategies and prospects in the treatment of rheumatoid arthritis.
Emami J; Ansarypour Z
Res Pharm Sci; 2019 Dec; 14(6):471-487. PubMed ID: 32038727
[TBL] [Abstract][Full Text] [Related]
13. MCTR3 reprograms arthritic monocytes to upregulate Arginase-1 and exert pro-resolving and tissue-protective functions in experimental arthritis.
Pistorius K; Ly L; Souza PR; Gomez EA; Koenis DS; Rodriguez AR; Foster J; Sosabowski J; Hopkinson M; Rajeeve V; Spur BW; Pitsillides A; Pitzalis C; Dalli J
EBioMedicine; 2022 May; 79():103974. PubMed ID: 35430453
[TBL] [Abstract][Full Text] [Related]
14. TLRs, future potential therapeutic targets for RA.
Elshabrawy HA; Essani AE; Szekanecz Z; Fox DA; Shahrara S
Autoimmun Rev; 2017 Feb; 16(2):103-113. PubMed ID: 27988432
[TBL] [Abstract][Full Text] [Related]
15. The limited capacity of malignant glioma-derived exosomes to suppress peripheral immune effectors.
Iorgulescu JB; Ivan ME; Safaee M; Parsa AT
J Neuroimmunol; 2016 Jan; 290():103-8. PubMed ID: 26711578
[TBL] [Abstract][Full Text] [Related]
16. Interrogating Circulating Microsomes and Exosomes Using Metal Nanoparticles.
Zhou YG; Mohamadi RM; Poudineh M; Kermanshah L; Ahmed S; Safaei TS; Stojcic J; Nam RK; Sargent EH; Kelley SO
Small; 2016 Feb; 12(6):727-32. PubMed ID: 26707703
[TBL] [Abstract][Full Text] [Related]
17. Exosomes and nanotubes: Control of immune cell communication.
McCoy-Simandle K; Hanna SJ; Cox D
Int J Biochem Cell Biol; 2016 Feb; 71():44-54. PubMed ID: 26704468
[TBL] [Abstract][Full Text] [Related]
18. Chromatographically isolated CD63+CD81+ extracellular vesicles from mesenchymal stromal cells rescue cognitive impairments after TBI.
Kim DK; Nishida H; An SY; Shetty AK; Bartosh TJ; Prockop DJ
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):170-5. PubMed ID: 26699510
[TBL] [Abstract][Full Text] [Related]
19. Isolation of Exosomes from Blood Plasma: Qualitative and Quantitative Comparison of Ultracentrifugation and Size Exclusion Chromatography Methods.
Baranyai T; Herczeg K; Onódi Z; Voszka I; Módos K; Marton N; Nagy G; Mäger I; Wood MJ; El Andaloussi S; Pálinkás Z; Kumar V; Nagy P; Kittel Á; Buzás EI; Ferdinandy P; Giricz Z
PLoS One; 2015; 10(12):e0145686. PubMed ID: 26690353
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of microRNA are altered with the development of shock in human sepsis: an observational study.
Goodwin AJ; Guo C; Cook JA; Wolf B; Halushka PV; Fan H
Crit Care; 2015 Dec; 19():440. PubMed ID: 26683209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
